HomeBiotech

Biotech

Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

September 23, 2023

Smarter Science: How Laboratory Automation Is Shaping the Future of Research and Diagnostics

Smarter Science: How Laboratory Automation Is Shaping the Future of Research and Diagnostics

September 23, 2023

Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard

Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard

September 23, 2023

RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

September 23, 2023

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

September 23, 2023

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

September 22, 2023

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

September 22, 2023

Unlocking the Future of Drug Discovery with Artificial Intelligence

Unlocking the Future of Drug Discovery with Artificial Intelligence

September 22, 2023

DNA Sequencing Market size to grow by USD 10.69 billion from 2022 to 2027, North America to account for 37% of market growth – Technavio

DNA Sequencing Market size to grow by USD 10.69 billion from 2022 to 2027, North America to account for 37% of market growth – Technavio

September 22, 2023

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

September 21, 2023

« 1 … 31 32 33 34 35 … 75 »